BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32063152)

  • 1. Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis.
    Nakano T; Mizumasa T; Kuroki Y; Eriguchi M; Yoshida H; Taniguchi M; Masutani K; Tsuruya K; Kitazono T
    Perit Dial Int; 2020 Jan; 40(1):67-75. PubMed ID: 32063152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucose degradation product methylglyoxal induces immature angiogenesis in patients undergoing peritoneal dialysis.
    Nakano T; Kumiko T; Mizumasa T; Kuroki Y; Tsuruya K; Kitazono T
    Biochem Biophys Res Commun; 2020 May; 525(3):767-772. PubMed ID: 32147098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis.
    Kawanishi K; Honda K; Tsukada M; Oda H; Nitta K
    Perit Dial Int; 2013; 33(3):242-51. PubMed ID: 23123670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
    Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
    Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal infusion of glucose-based dialysate in the rat--an animal model for the study of peritoneal advanced glycation end-products formation and effect on peritoneal transport.
    Zeltzer E; Klein O; Rashid G; Katz D; Korzets Z; Bernheim J
    Perit Dial Int; 2000; 20(6):656-61. PubMed ID: 11216555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between VEGF receptors and baseline peritoneal transport status in new peritoneal dialysis patients.
    Zhang AH; Wang G; Zhang DL; Zhang QD; Liu S; Liao Y; Yin Y; Liu WH
    Ren Fail; 2012; 34(5):582-9. PubMed ID: 22563920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients.
    Nakamoto H; Hamada C; Shimaoka T; Sekiguchi Y; Io H; Kaneko K; Horikoshi S; Tomino Y
    J Artif Organs; 2014 Mar; 17(1):60-8. PubMed ID: 24337623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose degradation products in peritoneal dialysis solution impair angiogenesis by dysregulating angiogenetic factors in endothelial and vascular smooth muscle cells.
    Aihara S; Nakano T; Torisu K; Kitazono T
    Clin Exp Nephrol; 2022 Dec; 26(12):1160-1169. PubMed ID: 36070106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2.
    Yuan J; Fang W; Ni Z; Dai H; Lin A; Cao L; Qian J
    Pediatr Nephrol; 2009 Jan; 24(1):163-70. PubMed ID: 18751736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
    Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
    Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.
    Honda K; Nitta K; Horita S; Yumura W; Nihei H; Nagai R; Ikeda K; Horiuchi S
    Nephrol Dial Transplant; 1999 Jun; 14(6):1541-9. PubMed ID: 10383022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients.
    Mahiout A; Ehlerding G; Brunkhorst R
    Nephrol Dial Transplant; 1996; 11 Suppl 5():2-6. PubMed ID: 9044298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
    Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
    Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs.
    Feriani M
    Contrib Nephrol; 2001; (131):74-81. PubMed ID: 11125565
    [No Abstract]   [Full Text] [Related]  

  • 17. Peritoneal thickening is not inevitable in long-term peritoneal dialysis and is associated with peritoneal transport characteristics: a two-centre sonographic study.
    Lee TC; Yang JY; Wang HP; Tsai TJ; Yang Y
    Nephrol Dial Transplant; 2008 Mar; 23(3):1005-10. PubMed ID: 18042613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy.
    Catar RA; Bartosova M; Kawka E; Chen L; Marinovic I; Zhang C; Zhao H; Wu D; Zickler D; Stadnik H; Karczewski M; Kamhieh-Milz J; Jörres A; Moll G; Schmitt CP; Witowski J
    Front Immunol; 2022; 13():821681. PubMed ID: 35185912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.